Department of Neurology and Neurosurgery, University of Tartu, L. Puusepa 8, 51014 Tartu, Estonia.
Parkinsons Dis. 2011 Feb 17;2011:865319. doi: 10.4061/2011/865319.
During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a "designer" psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe with some cases also in Western countries. A levodopa unresponsive Parkinsonian syndrome occurs within a few months of abusing the homemade drug mixture containing ephedrone (methcathinone) and manganese. The development of this neurological syndrome has been attributed to toxic effects of manganese, but the role of the psychostimulant ephedrone is unclear. This paper describes the clinical syndrome, results of neuroimaging, and therapeutic attempts.
近年来,在东欧的一些国家和一些西方国家的吸毒者中观察到一种与静脉注射用高锰酸钾氧化的伪麻黄碱衍生的“设计”兴奋剂相关的运动减少、构音障碍、肌张力障碍和姿势障碍综合征。在滥用含有(去甲麻黄碱)和锰的自制药物混合物后几个月内会出现左旋多巴反应性帕金森综合征。这种神经综合征的发展归因于锰的毒性作用,但兴奋剂去甲麻黄碱的作用尚不清楚。本文描述了该临床综合征、神经影像学结果和治疗尝试。